Long-term administration of 3,5-diodo-4(3'-iodo4'-acetoxyphenoxy) benzoic acid (acetiromate) in hyperlipidemic patients.
D000368:Aged; D002784:Cholesterol / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D007463:Iodobenzoates / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013974:Thyroxine / Q000097:blood; D013997:Time Factors
D000960:Hypolipidemic Agents; D007463:Iodobenzoates; D010647:Phenyl Ethers; C002002:acetiromate; D002784:Cholesterol; D013974:Thyroxine